Cleared Traditional

K102115 - ODFS PACE

K102115 is an FDA 510(k) clearance for ODFS PACE, manufactured by Odstock Medical, Ltd.. The device is a Class 2 Neurology device with product code GZI cleared through the Traditional 510(k) pathway after a 245-day FDA review.

K102115 · Odstock Medical, Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2011
Decision
245d
Days
Class 2
Risk

K102115 is an FDA 510(k) clearance for the ODFS PACE. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Odstock Medical, Ltd. (Salisbury, Wiltshire, GB). The FDA issued a Cleared decision on March 30, 2011 after a review of 245 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Odstock Medical, Ltd. devices

FDA 510(k) Submission Details - K102115

510(k) Number K102115 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 2010
Decision Date March 30, 2011
Days to Decision 245 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
97d slower than avg
Panel avg: 148d · This submission: 245d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZI Device Classification - Class 2, Special Controls

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 51
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K102115.
L300 PLUS SYSTEM (RIGHT, LEFT), L300 PLUS SYSTEM UPGRADE KIT (RIGHT, LEFT)
K103343 · Bioness, Inc. · Apr 2011
RT200
K103370 · Restorative Therapies, Inc. · Apr 2011
RT600
K103366 · Restorative Therapies, Inc. · Apr 2011
MODIFICATION TO:NESS L300
K080219 · Ness-Neuromuscular Electrical Stimulation Systems · Feb 2008
REHASTIM & REHAMOVE
K073237 · Hasomed GmbH · Dec 2007
RT300-S AND RT300-SP FES CYCLE ERGOMETER
K072398 · Restorative Therapies, Inc. · Nov 2007